Funding will expand the range of Dualase® genome editors for new high morbidity and mortality genetic disease targets. TORONTO, March 18, 2026 /PRNewswire/ - Specific Biologics Inc. ("Specific"), a biotechnology company developing industry-leading in vivo genome editing medicines to treat...
Hence then, the article about genome canada and ontario genomics award specific biologics and western university 1 8 million grant to develop a machine learning platform to accelerate the development of the company s dualase based therapeutics was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Genome Canada and Ontario Genomics Award Specific Biologics and Western University $1.8 Million Grant to Develop a Machine Learning Platform to Accelerate the Development of the Company's Dualase®-based Therapeutics )
Also on site :
- I’m an immigrant in limbo. Uni in the UK will cost me £250,000
- 1967 Rock Song, a No. 1 Hit by a 16-Year-Old Box Tops Member, Ranked Among ‘Greatest Songs of All Time’
- MPs call for UK to hold Israeli government to account for killing of journalists following Independent investigation